These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus. Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462 [TBL] [Abstract][Full Text] [Related]
3. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives]. Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343 [TBL] [Abstract][Full Text] [Related]
4. Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints. Jiang H; Gomez-Manzano C; Rivera-Molina Y; Lang FF; Conrad CA; Fueyo J Curr Opin Virol; 2015 Aug; 13():33-9. PubMed ID: 25863716 [TBL] [Abstract][Full Text] [Related]
5. Oncolytic adenoviruses for the treatment of brain tumors. Gomez-Manzano C; Fueyo J Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384 [TBL] [Abstract][Full Text] [Related]
18. Oncolytic viruses in cancer therapy. Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089 [TBL] [Abstract][Full Text] [Related]
19. From virotherapy to oncolytic immunotherapy: where are we now? Coffin RS Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656 [TBL] [Abstract][Full Text] [Related]
20. Oncolytic Virotherapy by HSV. Watanabe D; Goshima F Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]